vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and Lifeway Foods, Inc. (LWAY). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $55.4M, roughly 1.7× Lifeway Foods, Inc.). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -98.1%, a 102.7% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 18.0%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 11.4%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.

HIVE vs LWAY — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.7× larger
HIVE
$93.1M
$55.4M
LWAY
Growing faster (revenue YoY)
HIVE
HIVE
+200.6% gap
HIVE
218.6%
18.0%
LWAY
Higher net margin
LWAY
LWAY
102.7% more per $
LWAY
4.6%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
11.4%
LWAY

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
HIVE
HIVE
LWAY
LWAY
Revenue
$93.1M
$55.4M
Net Profit
$-91.3M
$2.5M
Gross Margin
-27.1%
27.8%
Operating Margin
6.8%
Net Margin
-98.1%
4.6%
Revenue YoY
218.6%
18.0%
Net Profit YoY
-234.0%
1688.1%
EPS (diluted)
$-0.38
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
LWAY
LWAY
Q4 25
$93.1M
$55.4M
Q3 25
$87.3M
$57.1M
Q2 25
$45.6M
$53.9M
Q1 25
$46.1M
Q4 24
$29.2M
$46.9M
Q3 24
$22.6M
$46.1M
Q2 24
$32.2M
$49.2M
Q1 24
$44.6M
Net Profit
HIVE
HIVE
LWAY
LWAY
Q4 25
$-91.3M
$2.5M
Q3 25
$-15.8M
$3.5M
Q2 25
$35.0M
$4.2M
Q1 25
$3.5M
Q4 24
$68.2M
$-160.0K
Q3 24
$80.0K
$3.0M
Q2 24
$-18.3M
$3.8M
Q1 24
$2.4M
Gross Margin
HIVE
HIVE
LWAY
LWAY
Q4 25
-27.1%
27.8%
Q3 25
4.7%
28.7%
Q2 25
-13.6%
28.6%
Q1 25
23.9%
Q4 24
-43.7%
25.3%
Q3 24
-66.1%
25.7%
Q2 24
-7.4%
27.0%
Q1 24
25.8%
Operating Margin
HIVE
HIVE
LWAY
LWAY
Q4 25
6.8%
Q3 25
8.8%
Q2 25
10.8%
Q1 25
3.4%
Q4 24
1.5%
Q3 24
9.1%
Q2 24
11.0%
Q1 24
8.0%
Net Margin
HIVE
HIVE
LWAY
LWAY
Q4 25
-98.1%
4.6%
Q3 25
-18.1%
6.2%
Q2 25
76.8%
7.9%
Q1 25
7.7%
Q4 24
233.2%
-0.3%
Q3 24
0.4%
6.5%
Q2 24
-56.7%
7.7%
Q1 24
5.4%
EPS (diluted)
HIVE
HIVE
LWAY
LWAY
Q4 25
$-0.38
$0.15
Q3 25
$-0.07
$0.23
Q2 25
$0.18
$0.28
Q1 25
$0.23
Q4 24
$0.52
$0.00
Q3 24
$0.00
$0.19
Q2 24
$-0.17
$0.25
Q1 24
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
LWAY
LWAY
Cash + ST InvestmentsLiquidity on hand
$5.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$85.8M
Total Assets
$624.0M
$105.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
LWAY
LWAY
Q4 25
$5.6M
Q3 25
$23.0M
Q2 25
$21.2M
Q1 25
$19.4M
Q4 24
$40.5M
$16.7M
Q3 24
$31.7M
$20.6M
Q2 24
$14.6M
Q1 24
$12.0M
Total Debt
HIVE
HIVE
LWAY
LWAY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
$2.5M
Stockholders' Equity
HIVE
HIVE
LWAY
LWAY
Q4 25
$559.3M
$85.8M
Q3 25
$624.6M
$82.8M
Q2 25
$560.5M
$78.7M
Q1 25
$74.2M
Q4 24
$430.9M
$71.9M
Q3 24
$275.5M
$71.5M
Q2 24
$268.6M
$68.0M
Q1 24
$63.5M
Total Assets
HIVE
HIVE
LWAY
LWAY
Q4 25
$624.0M
$105.6M
Q3 25
$693.0M
$109.5M
Q2 25
$628.7M
$98.3M
Q1 25
$93.7M
Q4 24
$478.6M
$90.5M
Q3 24
$334.7M
$91.3M
Q2 24
$84.9M
Q1 24
$82.8M
Debt / Equity
HIVE
HIVE
LWAY
LWAY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
0.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
LWAY
LWAY
Operating Cash FlowLast quarter
$46.0M
$267.0K
Free Cash FlowOCF − Capex
$-17.4M
FCF MarginFCF / Revenue
-31.5%
Capex IntensityCapex / Revenue
31.9%
Cash ConversionOCF / Net Profit
0.11×
TTM Free Cash FlowTrailing 4 quarters
$-16.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
LWAY
LWAY
Q4 25
$46.0M
$267.0K
Q3 25
$-10.6M
$6.9M
Q2 25
$10.2M
$3.9M
Q1 25
$-150.0K
Q4 24
$-28.5M
$-2.6M
Q3 24
$-2.2M
$7.5M
Q2 24
$-4.4M
$6.5M
Q1 24
$1.5M
Free Cash Flow
HIVE
HIVE
LWAY
LWAY
Q4 25
$-17.4M
Q3 25
$1.8M
Q2 25
$1.6M
Q1 25
$-2.4M
Q4 24
$-55.5M
$-3.8M
Q3 24
$-34.7M
$5.9M
Q2 24
$5.1M
Q1 24
$-923.0K
FCF Margin
HIVE
HIVE
LWAY
LWAY
Q4 25
-31.5%
Q3 25
3.1%
Q2 25
3.0%
Q1 25
-5.1%
Q4 24
-189.9%
-8.2%
Q3 24
-153.4%
12.8%
Q2 24
10.4%
Q1 24
-2.1%
Capex Intensity
HIVE
HIVE
LWAY
LWAY
Q4 25
31.9%
Q3 25
9.0%
Q2 25
4.3%
Q1 25
4.8%
Q4 24
92.5%
2.7%
Q3 24
143.9%
3.3%
Q2 24
2.9%
Q1 24
5.5%
Cash Conversion
HIVE
HIVE
LWAY
LWAY
Q4 25
0.11×
Q3 25
1.96×
Q2 25
0.29×
0.92×
Q1 25
-0.04×
Q4 24
-0.42×
Q3 24
-26.94×
2.50×
Q2 24
1.73×
Q1 24
0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIVE
HIVE

Segment breakdown not available.

LWAY
LWAY

Drinkable Kefirotherthan Pro Bugs$47.8M86%
Cheese$4.7M8%
Cream And Other$1.7M3%
Other$1.2M2%

Related Comparisons